Replies to post #50580 on Amarantus Bioscience Holdings Inc (AMBS)

[zoomboom]

That is correct, Thanks Mike AMBS & ARRAYIT JV should be announced soon also..

AMBS is covering all angles... they have a plan and its coming to fruition

AMBS$$$$$$$$$$

[Iron heart]

Parkinson’s Disease Therapeutics

Arrayit Corporation (OTCQB: ARYC) met with Amarantus Bioscience (OTCQB: AMBS), a leading company focused on the discovery and development of secreted proteins including MANF and small molecule therapeutics for the treatment Parkinson’s Disase and other neurological disorders. Shown in the photograph (left to right) are Dr. Paul Cannon from Tynan Consulting LLC, Dr. Essam Sheta from Oncology Consultants, Arrayit Corporation Chairman and CEO Rene Schena, Arrayit Corporation President and CSO Dr. Mark Schena, Amarantus Bioscience President and CEO Gerald Commissiong, Dr. Katherine Tynan from Tynan Consulting LLC, and Amarantus Bioscience CSO Dr. John Commissiong. Photo taken at Arrayit headquarters in Sunnyvale, CA on January 6, 2013.

FDA Approval
Arrayit PDx™ Pre-Symptomatic Test for Parkinson’s Disease will be submitted to the United Sates Food and Drug Administration (FDA) as a 510(k) submission in the near future.